Monarch Partners Asset Management LLC Vanda Pharmaceuticals Inc. Transaction History
Monarch Partners Asset Management LLC
- $328 Million
- Q4 2022
Shares
2 transactions
Others Institutions Holding VNDA
# of Institutions
156Shares Held
45.2MCall Options Held
86.1KPut Options Held
40.8K-
Black Rock Inc. New York, NY8.14MShares$36 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.85MShares$17 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$15.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.49MShares$11 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$10.4 Million0.85% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $250M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...